US Stock Market Move | New stock Turn Therapeutics (TTRX.US) surges over 144%, dedicated to developing next-generation therapies for skin diseases, wounds, and infections.

On Thursday, the stock price of the newly established company Turn Therapeutics (TTRX.US) rose by over 144%, reaching $16.95 as of the time of writing. Turn Therapeutics is committed to developing next-generation therapies for skin diseases, wounds, and infections. The company has a proprietary delivery platform technology called "PermaFusion," which is designed to allow water-soluble active ingredients to penetrate the skin, nails, or mucous membranes with an oily carrier without the need for emulsifiers, thereby enhancing availability and reducing irritation.